Sectors
DNTH
Dianthus Therapeutics, Inc.
105.61
4 x 105.23
2 x 106.07
bid
ask
-
0.23
0.22%
3 @ 04:20 PM
105.61 +0.00 (0.00%)
| Ytd | 156.27% | |
| 1y | 348.07% |
102.38
day range
107.19
23.39
52 week range
117.88
| Open | 105.34 | Prev Close | 105.84 | Low | 102.38 | High | 107.19 | Mkt Cap | 5.91B |
| Vol | 459.38K | Avg Vol | 1.05M | EPS | -4.24 | P/E | N/A | Forward P/E | -22.26 |
| Beta | 0.08 | Short Ratio | 10.01 | Inst. Own | 128.11% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 103.35 | 200-d Avg | 74.28 | 1yr Est | 137.62 |
| Income Statement | |||
| Total Revenue | 761.00K | ||
| Revenues (USD) | 761.00K | ||
| Gross Profit | 761.00K | ||
| Operating Expenses | 62.24M | ||
| Research and Development Expense | 48.69M | ||
| Selling, General and Administrative Expense | 13.56M | ||
| Operating Income | -61.48M | ||
| Net Income | -50.21M | ||
| Net Income Common Stock | -50.21M | ||
| Net Income Common Stock (USD) | -50.21M | ||
| Consolidated Income | -50.21M | ||
| Earnings per Basic Share | -0.90 | ||
| Earnings per Basic Share (USD) | -0.90 | ||
| Earnings per Diluted Share | -0.90 | ||
| Earning Before Interest & Taxes (EBIT) | -50.21M | ||
| Earning Before Interest & Taxes (USD) | -50.21M | ||
| Weighted Average Shares | 56.03M | ||
| Weighted Average Shares Diluted | 56.03M | ||
| Balance Sheet | |||
| Cash and Equivalents | 110.55M | ||
| Cash and Equivalents (USD) | 110.55M | ||
| Investments | 1.08B | ||
| Investments Current | 776.26M | ||
| Investments Non-Current | 303.63M | ||
| Trade and Non-Trade Receivables | 106.00K | ||
| Current Assets | 897.54M | ||
| Property, Plant & Equipment Net | 1.64M | ||
| Total Assets | 1.21B | ||
| Debt Current | 374.00K | ||
| Total Debt | 1.29M | ||
| Current Liabilities | 34.39M | ||
| Debt Non-Current | 913.00K | ||
| Total Liabilities | 41.25M | ||
| Accumulated Retained Earnings (Deficit) | -427.78M | ||
| Accumulated Other Comprehensive Income | -2.13M | ||
| Shareholders Equity | 1.17B | ||
| Shareholders Equity (USD) | 1.17B | ||
| Assets Non-Current | 315.73M | ||
| Total Debt (USD) | 1.29M | ||
| Deferred Revenue | 7.47M | ||
| Liabilities Non-Current | 6.86M | ||
| Trade and Non-Trade Payables | 6.39M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 107.00K | ||
| Net Cash Flow from Financing | 10.38M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -517.12M | ||
| Capital Expenditure | -181.00K | ||
| Issuance (Purchase) of Equity Shares | 10.58M | ||
| Net Cash Flow from Investing | -478.52M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -478.34M | ||
| Net Cash Flow from Operations | -48.98M | ||
| Share Based Compensation | 11.90M | ||